Advertisement

Index by author

March 01, 1990; Volume 252,Issue 3

A

  1. Abraham, R T

    1. Doxorubicin blocks the increase in intracellular Ca++, part of a second messenger system in N1E-115 murine neuroblastoma cells.
      S G Oakes, J J Schlager, K S Santone, R T Abraham and G Powis
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 979-983;

  2. Abrahamsson, T

    1. Chronic isoproterenol administration causes altered beta adrenoceptor-Gs-coupling in guinea pig lung.
      V Nerme, T Abrahamsson and G Vauquelin
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1341-1346;

  3. Adham, N

    1. Antagonist characterization of atypical beta adrenoceptors in guinea pig ileum: blockade by alprenolol and dihydroalprenolol.
      D R Blue, R A Bond, N Adham, R Delmendo, A D Michel, R M Eglen, R L Whiting and D E Clarke
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1034-1042;

  4. Althaus, W A

    1. Pharmacokinetics and disposition of the KS1/4 monoclonal antibody-desacetylvinblastine hydrazide conjugate LY203725 in rats and monkeys.
      T D Lindstrom, W A Althaus, K J Ruterbories and D Kau
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1117-1124;

  5. Austin, M C

    1. Enkephalinergic and GABAergic modulation of motor activity in the ventral pallidum.
      M C Austin and P W Kalivas
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1370-1377;

B

  1. Baker, R C

    1. Ethanol inhibits zymosan-stimulated and enhances nonstimulated platelet-activating factor production in a clonal macrophage cell line.
      R C Baker, M Tucker and K L Clay
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1028-1033;

  2. Balster, R L

    1. The self-administration of MK-801 can depend upon drug-reinforcement history, and its discriminative stimulus properties are phencyclidine-like in rhesus monkeys.
      P M Beardsley, B A Hayes and R L Balster
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 953-959;

  3. Barnes, P J

    1. A potassium channel activator modulates both excitatory noncholinergic and cholinergic neurotransmission in guinea pig airways.
      M Ichinose and P J Barnes
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1207-1212;

  4. Barnette, M S

    1. Activation of cyclic AMP-dependent protein kinase during canine lower esophageal sphincter relaxation.
      M S Barnette, M Grous, T J Torphy and H S Ormsbee
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1160-1166;

  5. Barrington, P L

    1. Characterization of the electrophysiological effects of metoprolol on isolated feline ventricular myocytes.
      P L Barrington and R E Ten Eick
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1043-1052;

  6. Beardsley, P M

    1. The self-administration of MK-801 can depend upon drug-reinforcement history, and its discriminative stimulus properties are phencyclidine-like in rhesus monkeys.
      P M Beardsley, B A Hayes and R L Balster
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 953-959;

  7. Bhargava, H N

    1. Modification of brain and spinal cord dopamine D1 receptors labeled with [3H]SCH 23390 after morphine withdrawal from tolerant and physically dependent rats.
      H N Bhargava and A Gulati
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 901-907;

  8. Billah, M M

    1. Sch 37370: a potent, orally active, dual antagonist of platelet-activating factor and histamine.
      M M Billah, R W Chapman, R W Egan, H Gilchrest, J J Piwinski, J Sherwood, M I Siegel, R E West and W Kreutner
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1090-1096;

  9. Bjur, R A

    1. Nerve and drug-induced release of adenine nucleosides and nucleotides from rabbit aorta.
      K O Sedaa, R A Bjur, K Shinozuka and D P Westfall
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1060-1067;

  10. Bloom, A S

    1. Studies of the role of membrane lipid order in the effects of delta 9-tetrahydrocannabinol on adenylate cyclase activation in heart.
      C J Hillard, J J Pounds, D R Boyer and A S Bloom
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1075-1082;

  11. Bloxham, D P

    1. Biologic properties of romazarit (Ro 31-3948), a potential disease-modifying antirheumatic drug.
      D P Bloxham, D Bradshaw, C H Cashin, B B Dodge, E J Lewis, D Westmacott and C R Self
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1331-1340;

  12. Blue, D R

    1. Antagonist characterization of atypical beta adrenoceptors in guinea pig ileum: blockade by alprenolol and dihydroalprenolol.
      D R Blue, R A Bond, N Adham, R Delmendo, A D Michel, R M Eglen, R L Whiting and D E Clarke
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1034-1042;

  13. Boarder, M R

    1. Role of phosphoinositide turnover and cyclic AMP accumulation in prostaglandin-stimulated noradrenaline release from cultured adrenal chromaffin cells.
      R Plevin, P J Owen, D B Marriott, J A Jones and M R Boarder
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1296-1303;

  14. Boisse, N R

    1. Tolerance and physical dependence to a short-acting benzodiazepine, midazolam.
      N R Boisse, N Quaglietta, G M Samoriski and J J Guarino
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1125-1133;

  15. Bond, R A

    1. Antagonist characterization of atypical beta adrenoceptors in guinea pig ileum: blockade by alprenolol and dihydroalprenolol.
      D R Blue, R A Bond, N Adham, R Delmendo, A D Michel, R M Eglen, R L Whiting and D E Clarke
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1034-1042;

  16. Boyer, D R

    1. Studies of the role of membrane lipid order in the effects of delta 9-tetrahydrocannabinol on adenylate cyclase activation in heart.
      C J Hillard, J J Pounds, D R Boyer and A S Bloom
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1075-1082;

  17. Bradshaw, D

    1. Biologic properties of romazarit (Ro 31-3948), a potential disease-modifying antirheumatic drug.
      D P Bloxham, D Bradshaw, C H Cashin, B B Dodge, E J Lewis, D Westmacott and C R Self
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1331-1340;

  18. Brady, J V

    1. Smoked marijuana effects on tobacco cigarette smoking behavior.
      T H Kelly, R W Foltin, A J Rose, M W Fischman and J V Brady
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 934-944;

  19. Brater, D C

    1. Intratubular albumin blunts the response to furosemide-A mechanism for diuretic resistance in the nephrotic syndrome.
      K A Kirchner, J R Voelker and D C Brater
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1097-1101;

  20. Breeding, M

    1. Serotonin1c receptor reserve in choroid plexus masks receptor subsensitivity.
      E Sanders-Bush and M Breeding
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 984-988;

  21. Breese, G R

    1. Neural adaptation in imipramine-treated rats processed in forced swim test: assessment of time course, handling, rat strain and amine uptake.
      I A Paul, G E Duncan, C Kuhn, R A Mueller, J S Hong and G R Breese
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 997-1005;

C

  1. Caliezi, A

    1. Different motor actions of dynorphins and nonpeptide kappa opioid receptor agonists in the isolated rat colon.
      U Scheurer, F Wenger, A Caliezi, E Drack, L Varga and F Halter
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1324-1330;

  2. Cashin, C H

    1. Biologic properties of romazarit (Ro 31-3948), a potential disease-modifying antirheumatic drug.
      D P Bloxham, D Bradshaw, C H Cashin, B B Dodge, E J Lewis, D Westmacott and C R Self
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1331-1340;

  3. Cass, W A

    1. Effects of the selective adenosine A2 receptor agonist CGS 21680 on in vitro electrophysiology, cAMP formation and dopamine release in rat hippocampus and striatum.
      C R Lupica, W A Cass, N R Zahniser and T V Dunwiddie
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1134-1141;

  4. Caudle, R M

    1. Mu opioid receptor activation reduces inhibitory postsynaptic potentials in hippocampal CA3 pyramidal cells of rat and guinea pig.
      R M Caudle and C Chavkin
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1361-1369;

  5. Cavero, I

    1. Functional validation of platelet-activating factor receptor sites characterized biochemically by a specific and reproducible [3H]platelet-activating factor binding in human platelets.
      L Tahraoui, A Floch and I Cavero
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1221-1227;

  6. Chapman, R W

    1. Sch 37370: a potent, orally active, dual antagonist of platelet-activating factor and histamine.
      M M Billah, R W Chapman, R W Egan, H Gilchrest, J J Piwinski, J Sherwood, M I Siegel, R E West and W Kreutner
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1090-1096;

  7. Chavkin, C

    1. Mu opioid receptor activation reduces inhibitory postsynaptic potentials in hippocampal CA3 pyramidal cells of rat and guinea pig.
      R M Caudle and C Chavkin
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1361-1369;

  8. Cheng, H Y

    1. Mechanism of inhibition of rat liver mitochondrial respiration by oxmetidine, an H2-receptor antagonist.
      G D Hoke, H Y Cheng, C K Mirabelli and G F Rush
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 908-914;

  9. Ciaranello, R D

    1. G-protein-linked serotonin receptors in mouse kidney exhibit identical properties to 5-HT1b receptors in brain.
      R D Ciaranello, G L Tan and R Dean
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1347-1354;

  10. Cipkus-Dubray, L A

    1. Factors affecting rabbit mesenteric artery smooth muscle sensitivity to calcium antagonists.
      K D Meisheri, G P Sage and L A Cipkus-Dubray
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1167-1174;

  11. Clarke, D E

    1. Antagonist characterization of atypical beta adrenoceptors in guinea pig ileum: blockade by alprenolol and dihydroalprenolol.
      D R Blue, R A Bond, N Adham, R Delmendo, A D Michel, R M Eglen, R L Whiting and D E Clarke
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1034-1042;
    2. Pharmacological characterization of a neuronal receptor for 5-hydroxytryptamine in guinea pig ileum with properties similar to the 5-hydroxytryptamine receptor.
      D A Craig and D E Clarke
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1378-1386;

  12. Clay, K L

    1. Ethanol inhibits zymosan-stimulated and enhances nonstimulated platelet-activating factor production in a clonal macrophage cell line.
      R C Baker, M Tucker and K L Clay
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1028-1033;

  13. Craft, R M

    1. Differential cross-tolerance to opioids in squirrel monkeys responding under a shock titration schedule.
      R M Craft and L A Dykstra
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 945-952;

  14. Cragoe, E J

    1. Modulation of bovine aortic alpha-2 receptors by Na+, 5'-guanylylimidodiphosphate, amiloride and ethylisopropylamiloride: evidence for receptor G-protein precoupling.
      G Jagadeesh, E J Cragoe and R C Deth
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1184-1196;

  15. Craig, D A

    1. Pharmacological characterization of a neuronal receptor for 5-hydroxytryptamine in guinea pig ileum with properties similar to the 5-hydroxytryptamine receptor.
      D A Craig and D E Clarke
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1378-1386;

D

  1. Dadan, J

    1. Cyclooxygenase products and atrial natriuretic peptide modulate renal response to endothelin.
      N Perico, J Dadan, M Gabanelli and G Remuzzi
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1213-1220;

  2. Dean, R

    1. G-protein-linked serotonin receptors in mouse kidney exhibit identical properties to 5-HT1b receptors in brain.
      R D Ciaranello, G L Tan and R Dean
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1347-1354;

  3. Delmendo, R

    1. Antagonist characterization of atypical beta adrenoceptors in guinea pig ileum: blockade by alprenolol and dihydroalprenolol.
      D R Blue, R A Bond, N Adham, R Delmendo, A D Michel, R M Eglen, R L Whiting and D E Clarke
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1034-1042;

  4. De Paulis, T

    1. Sodium-dependent isomerization of dopamine D-2 receptors characterized using [125I]epidepride, a high-affinity substituted benzamide ligand.
      K A Neve, R A Henningsen, J M Kinzie, T De Paulis, D E Schmidt, R M Kessler and A Janowsky
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1108-1116;

  5. Deth, R C

    1. Modulation of bovine aortic alpha-2 receptors by Na+, 5'-guanylylimidodiphosphate, amiloride and ethylisopropylamiloride: evidence for receptor G-protein precoupling.
      G Jagadeesh, E J Cragoe and R C Deth
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1184-1196;

  6. Dodge, B B

    1. Biologic properties of romazarit (Ro 31-3948), a potential disease-modifying antirheumatic drug.
      D P Bloxham, D Bradshaw, C H Cashin, B B Dodge, E J Lewis, D Westmacott and C R Self
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1331-1340;

  7. Drack, E

    1. Different motor actions of dynorphins and nonpeptide kappa opioid receptor agonists in the isolated rat colon.
      U Scheurer, F Wenger, A Caliezi, E Drack, L Varga and F Halter
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1324-1330;

  8. Drieman, J C

    1. Renal selective N-acetyl-gamma-glutamyl prodrugs. II. Carrier-mediated transport and intracellular conversion as determinants in the renal selectivity of N-acetyl-gamma-glutamyl sulfamethoxazole.
      J C Drieman, H H Thijssen and H A Struyker-Boudier
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1255-1260;

  9. Drummer, O H

    1. Biliary excretion and conjugation of diacid angiotensin-converting enzyme inhibitors.
      O H Drummer, J Nicolaci and D Iakovidis
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1202-1206;

  10. Duncan, G E

    1. Neural adaptation in imipramine-treated rats processed in forced swim test: assessment of time course, handling, rat strain and amine uptake.
      I A Paul, G E Duncan, C Kuhn, R A Mueller, J S Hong and G R Breese
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 997-1005;

  11. Dunwiddie, T V

    1. Effects of the selective adenosine A2 receptor agonist CGS 21680 on in vitro electrophysiology, cAMP formation and dopamine release in rat hippocampus and striatum.
      C R Lupica, W A Cass, N R Zahniser and T V Dunwiddie
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1134-1141;

  12. Dykstra, L A

    1. Differential cross-tolerance to opioids in squirrel monkeys responding under a shock titration schedule.
      R M Craft and L A Dykstra
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 945-952;

E

  1. Egan, R W

    1. Sch 37370: a potent, orally active, dual antagonist of platelet-activating factor and histamine.
      M M Billah, R W Chapman, R W Egan, H Gilchrest, J J Piwinski, J Sherwood, M I Siegel, R E West and W Kreutner
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1090-1096;

  2. Eglen, R M

    1. Antagonist characterization of atypical beta adrenoceptors in guinea pig ileum: blockade by alprenolol and dihydroalprenolol.
      D R Blue, R A Bond, N Adham, R Delmendo, A D Michel, R M Eglen, R L Whiting and D E Clarke
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1034-1042;

  3. Evans, S M

    1. Low-dose caffeine discrimination in humans.
      R R Griffiths, S M Evans, S J Heishman, K L Preston, C A Sannerud, B Wolf and P P Woodson
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 970-978;

F

  1. Fenwick, J W

    1. Effect of dose on nicotine's reinforcing, withdrawal-suppression and self-reported effects.
      J R Hughes, S W Gust, R M Keenan and J W Fenwick
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1175-1183;

  2. Fischman, M W

    1. Smoked marijuana effects on tobacco cigarette smoking behavior.
      T H Kelly, R W Foltin, A J Rose, M W Fischman and J V Brady
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 934-944;

  3. Flavahan, N A

    1. Electrophysiological analysis of adrenergic neurotransmission and its modulation by chronic denervation in canine saphenous veins.
      K Komori, N A Flavahan, V M Miller and P M Vanhoutte
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1197-1201;

  4. Floch, A

    1. Functional validation of platelet-activating factor receptor sites characterized biochemically by a specific and reproducible [3H]platelet-activating factor binding in human platelets.
      L Tahraoui, A Floch and I Cavero
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1221-1227;

  5. Foltin, R W

    1. Smoked marijuana effects on tobacco cigarette smoking behavior.
      T H Kelly, R W Foltin, A J Rose, M W Fischman and J V Brady
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 934-944;
    2. Differential development of tolerance to the effects of d-amphetamine and fenfluramine on food intake in baboons.
      R W Foltin
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 960-969;

  6. Fujimoto, S

    1. Effects of pimobendan, a cardiotonic and vasodilating agent with phosphodiesterase inhibiting properties, on isolated arteries and veins of rats.
      S Fujimoto and T Matsuda
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1304-1311;

  7. Fujiwara, M

    1. The Na(+)-dependent release of endogenous dopamine and noradrenaline from rat brain synaptosomes.
      M Okada, K Mine and M Fujiwara
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1283-1288;

  8. Furukawa, O

    1. Influences of stress on gastric alkaline secretion in rats.
      K Takeuchi, O Furukawa, M Okada, H Niida and S Okabe
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1228-1233;

  9. Furuya, Y

    1. Analgesia produced by E-2078, a systemically active dynorphin analog, in mice.
      T Nakazawa, Y Furuya, T Kaneko, K Yamatsu, H Yoshino and S Tachibana
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1247-1254;

G

  1. Gabanelli, M

    1. Cyclooxygenase products and atrial natriuretic peptide modulate renal response to endothelin.
      N Perico, J Dadan, M Gabanelli and G Remuzzi
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1213-1220;

  2. Gan, B S

    1. Distinct coronary artery receptor systems for epidermal growth factor-urogastrone.
      B S Gan and M D Hollenberg
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1277-1282;

  3. Gilchrest, H

    1. Sch 37370: a potent, orally active, dual antagonist of platelet-activating factor and histamine.
      M M Billah, R W Chapman, R W Egan, H Gilchrest, J J Piwinski, J Sherwood, M I Siegel, R E West and W Kreutner
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1090-1096;

  4. Giuliani, S

    1. Dual effects of cholecystokinin-octapeptide on duodenal motility of urethane-anesthetized rats.
      S Giuliani, I T Lippe, C A Maggi and A Meli
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1312-1317;

  5. Goyal, R K

    1. Effect of bradykinin on opossum esophageal longitudinal smooth muscle: evidence for novel bradykinin receptors.
      J K Saha, J N Sengupta and R K Goyal
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1012-1020;

  6. Griffiths, R R

    1. Low-dose caffeine discrimination in humans.
      R R Griffiths, S M Evans, S J Heishman, K L Preston, C A Sannerud, B Wolf and P P Woodson
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 970-978;

  7. Grous, M

    1. Activation of cyclic AMP-dependent protein kinase during canine lower esophageal sphincter relaxation.
      M S Barnette, M Grous, T J Torphy and H S Ormsbee
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1160-1166;

  8. Guarino, J J

    1. Tolerance and physical dependence to a short-acting benzodiazepine, midazolam.
      N R Boisse, N Quaglietta, G M Samoriski and J J Guarino
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1125-1133;

  9. Gulati, A

    1. Modification of brain and spinal cord dopamine D1 receptors labeled with [3H]SCH 23390 after morphine withdrawal from tolerant and physically dependent rats.
      H N Bhargava and A Gulati
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 901-907;

  10. Gust, S W

    1. Effect of dose on nicotine's reinforcing, withdrawal-suppression and self-reported effects.
      J R Hughes, S W Gust, R M Keenan and J W Fenwick
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1175-1183;

H

  1. Halter, F

    1. Different motor actions of dynorphins and nonpeptide kappa opioid receptor agonists in the isolated rat colon.
      U Scheurer, F Wenger, A Caliezi, E Drack, L Varga and F Halter
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1324-1330;

  2. Hayashi, K

    1. Effects of BRL 34915 (cromakalim) on renal hemodynamics and function in anesthetized dogs.
      K Hayashi, Y Matsumura, Y Yoshida, T Ohyama, K Hisaki, Y Suzuki and S Morimoto
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1240-1246;

  3. Hayes, B A

    1. The self-administration of MK-801 can depend upon drug-reinforcement history, and its discriminative stimulus properties are phencyclidine-like in rhesus monkeys.
      P M Beardsley, B A Hayes and R L Balster
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 953-959;

  4. Heishman, S J

    1. Low-dose caffeine discrimination in humans.
      R R Griffiths, S M Evans, S J Heishman, K L Preston, C A Sannerud, B Wolf and P P Woodson
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 970-978;

  5. Henningsen, R A

    1. Sodium-dependent isomerization of dopamine D-2 receptors characterized using [125I]epidepride, a high-affinity substituted benzamide ligand.
      K A Neve, R A Henningsen, J M Kinzie, T De Paulis, D E Schmidt, R M Kessler and A Janowsky
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1108-1116;

  6. Heyman, J S

    1. Mu antagonist and kappa agonist properties of beta-funaltrexamine (beta-FNA) in vivo: long-lasting spinal analgesia in mice.
      J A Qi, J S Heyman, R J Sheldon, R J Koslo and F Porreca
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1006-1011;

  7. Hillard, C J

    1. Studies of the role of membrane lipid order in the effects of delta 9-tetrahydrocannabinol on adenylate cyclase activation in heart.
      C J Hillard, J J Pounds, D R Boyer and A S Bloom
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1075-1082;

  8. Hisaki, K

    1. Effects of BRL 34915 (cromakalim) on renal hemodynamics and function in anesthetized dogs.
      K Hayashi, Y Matsumura, Y Yoshida, T Ohyama, K Hisaki, Y Suzuki and S Morimoto
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1240-1246;

  9. Hoke, G D

    1. Mechanism of inhibition of rat liver mitochondrial respiration by oxmetidine, an H2-receptor antagonist.
      G D Hoke, H Y Cheng, C K Mirabelli and G F Rush
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 908-914;

  10. Hollenberg, M D

    1. Distinct coronary artery receptor systems for epidermal growth factor-urogastrone.
      B S Gan and M D Hollenberg
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1277-1282;

  11. Hong, J S

    1. Neural adaptation in imipramine-treated rats processed in forced swim test: assessment of time course, handling, rat strain and amine uptake.
      I A Paul, G E Duncan, C Kuhn, R A Mueller, J S Hong and G R Breese
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 997-1005;

  12. Hughes, J R

    1. Effect of dose on nicotine's reinforcing, withdrawal-suppression and self-reported effects.
      J R Hughes, S W Gust, R M Keenan and J W Fenwick
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1175-1183;

I

  1. Iakovidis, D

    1. Biliary excretion and conjugation of diacid angiotensin-converting enzyme inhibitors.
      O H Drummer, J Nicolaci and D Iakovidis
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1202-1206;

  2. Ichinose, M

    1. A potassium channel activator modulates both excitatory noncholinergic and cholinergic neurotransmission in guinea pig airways.
      M Ichinose and P J Barnes
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1207-1212;

  3. Inoki, R

    1. Roles of substance P and somatostatin on transmission of nociceptive information induced by formalin in spinal cord.
      T Ohkubo, M Shibata, H Takahashi and R Inoki
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1261-1268;

J

  1. Jagadeesh, G

    1. Modulation of bovine aortic alpha-2 receptors by Na+, 5'-guanylylimidodiphosphate, amiloride and ethylisopropylamiloride: evidence for receptor G-protein precoupling.
      G Jagadeesh, E J Cragoe and R C Deth
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1184-1196;

  2. Janowsky, A

    1. Sodium-dependent isomerization of dopamine D-2 receptors characterized using [125I]epidepride, a high-affinity substituted benzamide ligand.
      K A Neve, R A Henningsen, J M Kinzie, T De Paulis, D E Schmidt, R M Kessler and A Janowsky
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1108-1116;

  3. Johns, R A

    1. Comparison of spectrophotometric and biological assays for nitric oxide (NO) and endothelium-derived relaxing factor (EDRF): nonspecificity of the diazotization reaction for NO and failure to detect EDRF.
      W R Tracey, J Linden, M J Peach and R A Johns
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 922-928;

  4. Jones, J A

    1. Role of phosphoinositide turnover and cyclic AMP accumulation in prostaglandin-stimulated noradrenaline release from cultured adrenal chromaffin cells.
      R Plevin, P J Owen, D B Marriott, J A Jones and M R Boarder
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1296-1303;

K

  1. Kalivas, P W

    1. Enkephalinergic and GABAergic modulation of motor activity in the ventral pallidum.
      M C Austin and P W Kalivas
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1370-1377;

  2. Kanai, Y

    1. Antagonism of gamma-aminobutyric acidA receptor-mediated responses by amino-gamma-carbolines.
      Y Kanai, O Wada and S Manabe
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1269-1276;

  3. Kaneko, T

    1. Analgesia produced by E-2078, a systemically active dynorphin analog, in mice.
      T Nakazawa, Y Furuya, T Kaneko, K Yamatsu, H Yoshino and S Tachibana
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1247-1254;

  4. Kaplan, D S

    1. Mechanisms of gastric proton pump inhibition by calcium channel antagonists.
      J Nandi, R L King, D S Kaplan and R A Levine
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1102-1107;

  5. Kau, D

    1. Pharmacokinetics and disposition of the KS1/4 monoclonal antibody-desacetylvinblastine hydrazide conjugate LY203725 in rats and monkeys.
      T D Lindstrom, W A Althaus, K J Ruterbories and D Kau
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1117-1124;

  6. Kauffman, F C

    1. O2-dependent hepatotoxicity due to ethylhexanol in the perfused rat liver: mitochondria as a site of action.
      B J Keller, H Yamanaka, D C Liang, F C Kauffman and R G Thurman
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1355-1360;

  7. Kawai, Y

    1. Age-related changes in relaxant response of vascular smooth muscles to atrial natriuretic peptide.
      Y Kawai and T Ohhashi
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1234-1239;

  8. Keenan, R M

    1. Effect of dose on nicotine's reinforcing, withdrawal-suppression and self-reported effects.
      J R Hughes, S W Gust, R M Keenan and J W Fenwick
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1175-1183;

  9. Keller, B J

    1. O2-dependent hepatotoxicity due to ethylhexanol in the perfused rat liver: mitochondria as a site of action.
      B J Keller, H Yamanaka, D C Liang, F C Kauffman and R G Thurman
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1355-1360;

  10. Kelly, T H

    1. Smoked marijuana effects on tobacco cigarette smoking behavior.
      T H Kelly, R W Foltin, A J Rose, M W Fischman and J V Brady
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 934-944;

  11. Kessler, R M

    1. Sodium-dependent isomerization of dopamine D-2 receptors characterized using [125I]epidepride, a high-affinity substituted benzamide ligand.
      K A Neve, R A Henningsen, J M Kinzie, T De Paulis, D E Schmidt, R M Kessler and A Janowsky
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1108-1116;

  12. Killam, A L

    1. Comparison of two different arterial tissues suggests possible 5-hydroxytryptamine2 receptor heterogeneity.
      A L Killam, S S Nikam, G M Lambert, A R Martin and D L Nelson
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1083-1089;

  13. King, R L

    1. Mechanisms of gastric proton pump inhibition by calcium channel antagonists.
      J Nandi, R L King, D S Kaplan and R A Levine
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1102-1107;

  14. Kinzie, J M

    1. Sodium-dependent isomerization of dopamine D-2 receptors characterized using [125I]epidepride, a high-affinity substituted benzamide ligand.
      K A Neve, R A Henningsen, J M Kinzie, T De Paulis, D E Schmidt, R M Kessler and A Janowsky
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1108-1116;

  15. Kirchner, K A

    1. Intratubular albumin blunts the response to furosemide-A mechanism for diuretic resistance in the nephrotic syndrome.
      K A Kirchner, J R Voelker and D C Brater
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1097-1101;

  16. Komori, K

    1. Electrophysiological analysis of adrenergic neurotransmission and its modulation by chronic denervation in canine saphenous veins.
      K Komori, N A Flavahan, V M Miller and P M Vanhoutte
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1197-1201;

  17. Koslo, R J

    1. Mu antagonist and kappa agonist properties of beta-funaltrexamine (beta-FNA) in vivo: long-lasting spinal analgesia in mice.
      J A Qi, J S Heyman, R J Sheldon, R J Koslo and F Porreca
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1006-1011;

  18. Kreutner, W

    1. Sch 37370: a potent, orally active, dual antagonist of platelet-activating factor and histamine.
      M M Billah, R W Chapman, R W Egan, H Gilchrest, J J Piwinski, J Sherwood, M I Siegel, R E West and W Kreutner
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1090-1096;

  19. Kuhn, C

    1. Neural adaptation in imipramine-treated rats processed in forced swim test: assessment of time course, handling, rat strain and amine uptake.
      I A Paul, G E Duncan, C Kuhn, R A Mueller, J S Hong and G R Breese
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 997-1005;

L

  1. Lambert, G M

    1. Comparison of two different arterial tissues suggests possible 5-hydroxytryptamine2 receptor heterogeneity.
      A L Killam, S S Nikam, G M Lambert, A R Martin and D L Nelson
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1083-1089;

  2. Levine, R A

    1. Mechanisms of gastric proton pump inhibition by calcium channel antagonists.
      J Nandi, R L King, D S Kaplan and R A Levine
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1102-1107;

  3. Lewis, E J

    1. Biologic properties of romazarit (Ro 31-3948), a potential disease-modifying antirheumatic drug.
      D P Bloxham, D Bradshaw, C H Cashin, B B Dodge, E J Lewis, D Westmacott and C R Self
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1331-1340;

  4. Liang, D C

    1. O2-dependent hepatotoxicity due to ethylhexanol in the perfused rat liver: mitochondria as a site of action.
      B J Keller, H Yamanaka, D C Liang, F C Kauffman and R G Thurman
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1355-1360;

  5. Linden, J

    1. Comparison of spectrophotometric and biological assays for nitric oxide (NO) and endothelium-derived relaxing factor (EDRF): nonspecificity of the diazotization reaction for NO and failure to detect EDRF.
      W R Tracey, J Linden, M J Peach and R A Johns
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 922-928;

  6. Lindstrom, T D

    1. Pharmacokinetics and disposition of the KS1/4 monoclonal antibody-desacetylvinblastine hydrazide conjugate LY203725 in rats and monkeys.
      T D Lindstrom, W A Althaus, K J Ruterbories and D Kau
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1117-1124;

  7. Lippe, I T

    1. Dual effects of cholecystokinin-octapeptide on duodenal motility of urethane-anesthetized rats.
      S Giuliani, I T Lippe, C A Maggi and A Meli
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1312-1317;

  8. Lupica, C R

    1. Effects of the selective adenosine A2 receptor agonist CGS 21680 on in vitro electrophysiology, cAMP formation and dopamine release in rat hippocampus and striatum.
      C R Lupica, W A Cass, N R Zahniser and T V Dunwiddie
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1134-1141;

M

  1. Maggi, C A

    1. Dual effects of cholecystokinin-octapeptide on duodenal motility of urethane-anesthetized rats.
      S Giuliani, I T Lippe, C A Maggi and A Meli
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1312-1317;

  2. Maki, Y

    1. Possible mechanism for the inhibition of acid formation by the proton pump inhibitor AG-1749 in isolated canine parietal cells.
      H Nagaya, H Satoh and Y Maki
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1289-1295;

  3. Manabe, S

    1. Antagonism of gamma-aminobutyric acidA receptor-mediated responses by amino-gamma-carbolines.
      Y Kanai, O Wada and S Manabe
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1269-1276;

  4. Marriott, D B

    1. Role of phosphoinositide turnover and cyclic AMP accumulation in prostaglandin-stimulated noradrenaline release from cultured adrenal chromaffin cells.
      R Plevin, P J Owen, D B Marriott, J A Jones and M R Boarder
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1296-1303;

  5. Martin, A R

    1. Comparison of two different arterial tissues suggests possible 5-hydroxytryptamine2 receptor heterogeneity.
      A L Killam, S S Nikam, G M Lambert, A R Martin and D L Nelson
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1083-1089;

  6. Matsuda, T

    1. Effects of pimobendan, a cardiotonic and vasodilating agent with phosphodiesterase inhibiting properties, on isolated arteries and veins of rats.
      S Fujimoto and T Matsuda
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1304-1311;

  7. Matsumura, Y

    1. Effects of BRL 34915 (cromakalim) on renal hemodynamics and function in anesthetized dogs.
      K Hayashi, Y Matsumura, Y Yoshida, T Ohyama, K Hisaki, Y Suzuki and S Morimoto
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1240-1246;

  8. Meisheri, K D

    1. Factors affecting rabbit mesenteric artery smooth muscle sensitivity to calcium antagonists.
      K D Meisheri, G P Sage and L A Cipkus-Dubray
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1167-1174;

  9. Meli, A

    1. Dual effects of cholecystokinin-octapeptide on duodenal motility of urethane-anesthetized rats.
      S Giuliani, I T Lippe, C A Maggi and A Meli
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1312-1317;

  10. Michel, A D

    1. Antagonist characterization of atypical beta adrenoceptors in guinea pig ileum: blockade by alprenolol and dihydroalprenolol.
      D R Blue, R A Bond, N Adham, R Delmendo, A D Michel, R M Eglen, R L Whiting and D E Clarke
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1034-1042;

  11. Miller, V M

    1. Electrophysiological analysis of adrenergic neurotransmission and its modulation by chronic denervation in canine saphenous veins.
      K Komori, N A Flavahan, V M Miller and P M Vanhoutte
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1197-1201;

  12. Mine, K

    1. The Na(+)-dependent release of endogenous dopamine and noradrenaline from rat brain synaptosomes.
      M Okada, K Mine and M Fujiwara
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1283-1288;

  13. Mirabelli, C K

    1. Mechanism of inhibition of rat liver mitochondrial respiration by oxmetidine, an H2-receptor antagonist.
      G D Hoke, H Y Cheng, C K Mirabelli and G F Rush
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 908-914;

  14. Mok, L L

    1. Role of thromboxane A2/prostaglandin H2 receptor in the vasoconstrictor response of rat aorta to endothelin.
      E E Reynolds and L L Mok
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 915-921;

  15. Morimoto, S

    1. Effects of BRL 34915 (cromakalim) on renal hemodynamics and function in anesthetized dogs.
      K Hayashi, Y Matsumura, Y Yoshida, T Ohyama, K Hisaki, Y Suzuki and S Morimoto
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1240-1246;

  16. Morón, M A

    1. The antiseizure activity of dihydropyridine calcium channel antagonists in the conscious rat.
      M A Morón, C W Stevens and T L Yaksh
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1150-1155;

  17. Mueller, R A

    1. Neural adaptation in imipramine-treated rats processed in forced swim test: assessment of time course, handling, rat strain and amine uptake.
      I A Paul, G E Duncan, C Kuhn, R A Mueller, J S Hong and G R Breese
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 997-1005;

N

  1. Nagaya, H

    1. Possible mechanism for the inhibition of acid formation by the proton pump inhibitor AG-1749 in isolated canine parietal cells.
      H Nagaya, H Satoh and Y Maki
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1289-1295;

  2. Nakazawa, T

    1. Analgesia produced by E-2078, a systemically active dynorphin analog, in mice.
      T Nakazawa, Y Furuya, T Kaneko, K Yamatsu, H Yoshino and S Tachibana
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1247-1254;

  3. Nandi, J

    1. Mechanisms of gastric proton pump inhibition by calcium channel antagonists.
      J Nandi, R L King, D S Kaplan and R A Levine
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1102-1107;

  4. Narahashi, T

    1. Potent blocking action of chlorpromazine on two types of calcium channels in cultured neuroblastoma cells.
      N Ogata and T Narahashi
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1142-1149;

  5. Nelson, D L

    1. Comparison of two different arterial tissues suggests possible 5-hydroxytryptamine2 receptor heterogeneity.
      A L Killam, S S Nikam, G M Lambert, A R Martin and D L Nelson
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1083-1089;

  6. Nerme, V

    1. Chronic isoproterenol administration causes altered beta adrenoceptor-Gs-coupling in guinea pig lung.
      V Nerme, T Abrahamsson and G Vauquelin
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1341-1346;

  7. Neve, K A

    1. Sodium-dependent isomerization of dopamine D-2 receptors characterized using [125I]epidepride, a high-affinity substituted benzamide ligand.
      K A Neve, R A Henningsen, J M Kinzie, T De Paulis, D E Schmidt, R M Kessler and A Janowsky
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1108-1116;

  8. Ngai, J H

    1. Effects of endothelium on basal tone and agonist and O2 sensitivity in porcine coronary artery.
      J H Ngai, P S Roth and R J Paul
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1053-1059;

  9. Nicolaci, J

    1. Biliary excretion and conjugation of diacid angiotensin-converting enzyme inhibitors.
      O H Drummer, J Nicolaci and D Iakovidis
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1202-1206;

  10. Niida, H

    1. Influences of stress on gastric alkaline secretion in rats.
      K Takeuchi, O Furukawa, M Okada, H Niida and S Okabe
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1228-1233;

  11. Nikam, S S

    1. Comparison of two different arterial tissues suggests possible 5-hydroxytryptamine2 receptor heterogeneity.
      A L Killam, S S Nikam, G M Lambert, A R Martin and D L Nelson
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1083-1089;

O

  1. O'Donnell, S R

    1. Pinacidil antagonism of endothelin-induced contractions of smooth muscle in the lungs: differences between tracheal and pulmonary artery preparations.
      S R O'Donnell, J C Wanstall and X P Zeng
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1318-1323;

  2. Oakes, S G

    1. Doxorubicin blocks the increase in intracellular Ca++, part of a second messenger system in N1E-115 murine neuroblastoma cells.
      S G Oakes, J J Schlager, K S Santone, R T Abraham and G Powis
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 979-983;

  3. Ogata, N

    1. Potent blocking action of chlorpromazine on two types of calcium channels in cultured neuroblastoma cells.
      N Ogata and T Narahashi
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1142-1149;

  4. Ohhashi, T

    1. Age-related changes in relaxant response of vascular smooth muscles to atrial natriuretic peptide.
      Y Kawai and T Ohhashi
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1234-1239;

  5. Ohkubo, T

    1. Roles of substance P and somatostatin on transmission of nociceptive information induced by formalin in spinal cord.
      T Ohkubo, M Shibata, H Takahashi and R Inoki
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1261-1268;

  6. Ohyama, T

    1. Effects of BRL 34915 (cromakalim) on renal hemodynamics and function in anesthetized dogs.
      K Hayashi, Y Matsumura, Y Yoshida, T Ohyama, K Hisaki, Y Suzuki and S Morimoto
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1240-1246;

  7. Okabe, S

    1. Influences of stress on gastric alkaline secretion in rats.
      K Takeuchi, O Furukawa, M Okada, H Niida and S Okabe
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1228-1233;

  8. Okada, M

    1. Influences of stress on gastric alkaline secretion in rats.
      K Takeuchi, O Furukawa, M Okada, H Niida and S Okabe
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1228-1233;
    2. The Na(+)-dependent release of endogenous dopamine and noradrenaline from rat brain synaptosomes.
      M Okada, K Mine and M Fujiwara
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1283-1288;

  9. Ormsbee, H S

    1. Activation of cyclic AMP-dependent protein kinase during canine lower esophageal sphincter relaxation.
      M S Barnette, M Grous, T J Torphy and H S Ormsbee
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1160-1166;

  10. Owen, P J

    1. Role of phosphoinositide turnover and cyclic AMP accumulation in prostaglandin-stimulated noradrenaline release from cultured adrenal chromaffin cells.
      R Plevin, P J Owen, D B Marriott, J A Jones and M R Boarder
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1296-1303;

P

  1. Page, R D

    1. Prostaglandin F2 alpha inhibits acidification in H(+)-secreting epithelia.
      R D Page and T Yorio
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 929-933;

  2. Paul, I A

    1. Neural adaptation in imipramine-treated rats processed in forced swim test: assessment of time course, handling, rat strain and amine uptake.
      I A Paul, G E Duncan, C Kuhn, R A Mueller, J S Hong and G R Breese
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 997-1005;

  3. Paul, R J

    1. Effects of endothelium on basal tone and agonist and O2 sensitivity in porcine coronary artery.
      J H Ngai, P S Roth and R J Paul
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1053-1059;

  4. Peach, M J

    1. Comparison of spectrophotometric and biological assays for nitric oxide (NO) and endothelium-derived relaxing factor (EDRF): nonspecificity of the diazotization reaction for NO and failure to detect EDRF.
      W R Tracey, J Linden, M J Peach and R A Johns
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 922-928;

  5. Perico, N

    1. Cyclooxygenase products and atrial natriuretic peptide modulate renal response to endothelin.
      N Perico, J Dadan, M Gabanelli and G Remuzzi
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1213-1220;

  6. Piwinski, J J

    1. Sch 37370: a potent, orally active, dual antagonist of platelet-activating factor and histamine.
      M M Billah, R W Chapman, R W Egan, H Gilchrest, J J Piwinski, J Sherwood, M I Siegel, R E West and W Kreutner
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1090-1096;

  7. Plevin, R

    1. Role of phosphoinositide turnover and cyclic AMP accumulation in prostaglandin-stimulated noradrenaline release from cultured adrenal chromaffin cells.
      R Plevin, P J Owen, D B Marriott, J A Jones and M R Boarder
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1296-1303;

  8. Porreca, F

    1. Mu antagonist and kappa agonist properties of beta-funaltrexamine (beta-FNA) in vivo: long-lasting spinal analgesia in mice.
      J A Qi, J S Heyman, R J Sheldon, R J Koslo and F Porreca
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1006-1011;

  9. Pounds, J J

    1. Studies of the role of membrane lipid order in the effects of delta 9-tetrahydrocannabinol on adenylate cyclase activation in heart.
      C J Hillard, J J Pounds, D R Boyer and A S Bloom
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1075-1082;

  10. Powis, G

    1. Doxorubicin blocks the increase in intracellular Ca++, part of a second messenger system in N1E-115 murine neuroblastoma cells.
      S G Oakes, J J Schlager, K S Santone, R T Abraham and G Powis
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 979-983;

  11. Preston, K L

    1. Low-dose caffeine discrimination in humans.
      R R Griffiths, S M Evans, S J Heishman, K L Preston, C A Sannerud, B Wolf and P P Woodson
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 970-978;

  12. Puig, M M

    1. Effect of pertussis toxin on the interaction of azepexole and halothane.
      M M Puig, H Turndorf and W Warner
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1156-1159;

Q

  1. Qi, J A

    1. Mu antagonist and kappa agonist properties of beta-funaltrexamine (beta-FNA) in vivo: long-lasting spinal analgesia in mice.
      J A Qi, J S Heyman, R J Sheldon, R J Koslo and F Porreca
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1006-1011;

  2. Quaglietta, N

    1. Tolerance and physical dependence to a short-acting benzodiazepine, midazolam.
      N R Boisse, N Quaglietta, G M Samoriski and J J Guarino
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1125-1133;

R

  1. Rabin, R A

    1. Chronic ethanol exposure of PC 12 cells alters adenylate cyclase activity and intracellular cyclic AMP content.
      R A Rabin
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1021-1027;

  2. Remuzzi, G

    1. Cyclooxygenase products and atrial natriuretic peptide modulate renal response to endothelin.
      N Perico, J Dadan, M Gabanelli and G Remuzzi
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1213-1220;

  3. Reynolds, E E

    1. Role of thromboxane A2/prostaglandin H2 receptor in the vasoconstrictor response of rat aorta to endothelin.
      E E Reynolds and L L Mok
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 915-921;

  4. Rose, A J

    1. Smoked marijuana effects on tobacco cigarette smoking behavior.
      T H Kelly, R W Foltin, A J Rose, M W Fischman and J V Brady
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 934-944;

  5. Roth, P S

    1. Effects of endothelium on basal tone and agonist and O2 sensitivity in porcine coronary artery.
      J H Ngai, P S Roth and R J Paul
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1053-1059;

  6. Roth, R H

    1. Modulation of mesoprefrontal dopamine neurons by central benzodiazepine receptors. I. Pharmacological characterization.
      S Y Tam and R H Roth
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 989-996;

  7. Roy, D

    1. Covalent binding of phenytoin to protein and modulation of phenytoin metabolism by thiols in A/J mouse liver microsomes.
      D Roy and W R Snodgrass
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 895-900;

  8. Rush, G F

    1. Mechanism of inhibition of rat liver mitochondrial respiration by oxmetidine, an H2-receptor antagonist.
      G D Hoke, H Y Cheng, C K Mirabelli and G F Rush
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 908-914;

  9. Ruterbories, K J

    1. Pharmacokinetics and disposition of the KS1/4 monoclonal antibody-desacetylvinblastine hydrazide conjugate LY203725 in rats and monkeys.
      T D Lindstrom, W A Althaus, K J Ruterbories and D Kau
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1117-1124;

S

  1. Sage, G P

    1. Factors affecting rabbit mesenteric artery smooth muscle sensitivity to calcium antagonists.
      K D Meisheri, G P Sage and L A Cipkus-Dubray
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1167-1174;

  2. Saha, J K

    1. Effect of bradykinin on opossum esophageal longitudinal smooth muscle: evidence for novel bradykinin receptors.
      J K Saha, J N Sengupta and R K Goyal
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1012-1020;

  3. Samoriski, G M

    1. Tolerance and physical dependence to a short-acting benzodiazepine, midazolam.
      N R Boisse, N Quaglietta, G M Samoriski and J J Guarino
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1125-1133;

  4. Sanders-Bush, E

    1. Serotonin1c receptor reserve in choroid plexus masks receptor subsensitivity.
      E Sanders-Bush and M Breeding
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 984-988;

  5. Sannerud, C A

    1. Low-dose caffeine discrimination in humans.
      R R Griffiths, S M Evans, S J Heishman, K L Preston, C A Sannerud, B Wolf and P P Woodson
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 970-978;

  6. Santone, K S

    1. Doxorubicin blocks the increase in intracellular Ca++, part of a second messenger system in N1E-115 murine neuroblastoma cells.
      S G Oakes, J J Schlager, K S Santone, R T Abraham and G Powis
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 979-983;

  7. Satoh, H

    1. Possible mechanism for the inhibition of acid formation by the proton pump inhibitor AG-1749 in isolated canine parietal cells.
      H Nagaya, H Satoh and Y Maki
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1289-1295;

  8. Scheurer, U

    1. Different motor actions of dynorphins and nonpeptide kappa opioid receptor agonists in the isolated rat colon.
      U Scheurer, F Wenger, A Caliezi, E Drack, L Varga and F Halter
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1324-1330;

  9. Schlager, J J

    1. Doxorubicin blocks the increase in intracellular Ca++, part of a second messenger system in N1E-115 murine neuroblastoma cells.
      S G Oakes, J J Schlager, K S Santone, R T Abraham and G Powis
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 979-983;

  10. Schmidt, D E

    1. Sodium-dependent isomerization of dopamine D-2 receptors characterized using [125I]epidepride, a high-affinity substituted benzamide ligand.
      K A Neve, R A Henningsen, J M Kinzie, T De Paulis, D E Schmidt, R M Kessler and A Janowsky
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1108-1116;

  11. Sedaa, K O

    1. Nerve and drug-induced release of adenine nucleosides and nucleotides from rabbit aorta.
      K O Sedaa, R A Bjur, K Shinozuka and D P Westfall
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1060-1067;

  12. Self, C R

    1. Biologic properties of romazarit (Ro 31-3948), a potential disease-modifying antirheumatic drug.
      D P Bloxham, D Bradshaw, C H Cashin, B B Dodge, E J Lewis, D Westmacott and C R Self
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1331-1340;

  13. Sengupta, J N

    1. Effect of bradykinin on opossum esophageal longitudinal smooth muscle: evidence for novel bradykinin receptors.
      J K Saha, J N Sengupta and R K Goyal
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1012-1020;

  14. Sheldon, R J

    1. Mu antagonist and kappa agonist properties of beta-funaltrexamine (beta-FNA) in vivo: long-lasting spinal analgesia in mice.
      J A Qi, J S Heyman, R J Sheldon, R J Koslo and F Porreca
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1006-1011;

  15. Sherwood, J

    1. Sch 37370: a potent, orally active, dual antagonist of platelet-activating factor and histamine.
      M M Billah, R W Chapman, R W Egan, H Gilchrest, J J Piwinski, J Sherwood, M I Siegel, R E West and W Kreutner
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1090-1096;

  16. Shibata, M

    1. Roles of substance P and somatostatin on transmission of nociceptive information induced by formalin in spinal cord.
      T Ohkubo, M Shibata, H Takahashi and R Inoki
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1261-1268;

  17. Shinozuka, K

    1. Nerve and drug-induced release of adenine nucleosides and nucleotides from rabbit aorta.
      K O Sedaa, R A Bjur, K Shinozuka and D P Westfall
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1060-1067;

  18. Siegel, M I

    1. Sch 37370: a potent, orally active, dual antagonist of platelet-activating factor and histamine.
      M M Billah, R W Chapman, R W Egan, H Gilchrest, J J Piwinski, J Sherwood, M I Siegel, R E West and W Kreutner
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1090-1096;

  19. Singer, H A

    1. Phorbol ester-induced stress and myosin light chain phosphorylation in swine carotid medial smooth muscle.
      H A Singer
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1068-1074;

  20. Snodgrass, W R

    1. Covalent binding of phenytoin to protein and modulation of phenytoin metabolism by thiols in A/J mouse liver microsomes.
      D Roy and W R Snodgrass
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 895-900;

  21. Stevens, C W

    1. The antiseizure activity of dihydropyridine calcium channel antagonists in the conscious rat.
      M A Morón, C W Stevens and T L Yaksh
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1150-1155;

  22. Struyker-Boudier, H A

    1. Renal selective N-acetyl-gamma-glutamyl prodrugs. II. Carrier-mediated transport and intracellular conversion as determinants in the renal selectivity of N-acetyl-gamma-glutamyl sulfamethoxazole.
      J C Drieman, H H Thijssen and H A Struyker-Boudier
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1255-1260;

  23. Suzuki, Y

    1. Effects of BRL 34915 (cromakalim) on renal hemodynamics and function in anesthetized dogs.
      K Hayashi, Y Matsumura, Y Yoshida, T Ohyama, K Hisaki, Y Suzuki and S Morimoto
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1240-1246;

T

  1. Tachibana, S

    1. Analgesia produced by E-2078, a systemically active dynorphin analog, in mice.
      T Nakazawa, Y Furuya, T Kaneko, K Yamatsu, H Yoshino and S Tachibana
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1247-1254;

  2. Tahraoui, L

    1. Functional validation of platelet-activating factor receptor sites characterized biochemically by a specific and reproducible [3H]platelet-activating factor binding in human platelets.
      L Tahraoui, A Floch and I Cavero
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1221-1227;

  3. Takahashi, H

    1. Roles of substance P and somatostatin on transmission of nociceptive information induced by formalin in spinal cord.
      T Ohkubo, M Shibata, H Takahashi and R Inoki
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1261-1268;

  4. Takeuchi, K

    1. Influences of stress on gastric alkaline secretion in rats.
      K Takeuchi, O Furukawa, M Okada, H Niida and S Okabe
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1228-1233;

  5. Tam, S Y

    1. Modulation of mesoprefrontal dopamine neurons by central benzodiazepine receptors. I. Pharmacological characterization.
      S Y Tam and R H Roth
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 989-996;

  6. Tan, G L

    1. G-protein-linked serotonin receptors in mouse kidney exhibit identical properties to 5-HT1b receptors in brain.
      R D Ciaranello, G L Tan and R Dean
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1347-1354;

  7. Ten Eick, R E

    1. Characterization of the electrophysiological effects of metoprolol on isolated feline ventricular myocytes.
      P L Barrington and R E Ten Eick
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1043-1052;

  8. Thijssen, H H

    1. Renal selective N-acetyl-gamma-glutamyl prodrugs. II. Carrier-mediated transport and intracellular conversion as determinants in the renal selectivity of N-acetyl-gamma-glutamyl sulfamethoxazole.
      J C Drieman, H H Thijssen and H A Struyker-Boudier
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1255-1260;

  9. Thurman, R G

    1. O2-dependent hepatotoxicity due to ethylhexanol in the perfused rat liver: mitochondria as a site of action.
      B J Keller, H Yamanaka, D C Liang, F C Kauffman and R G Thurman
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1355-1360;

  10. Torphy, T J

    1. Activation of cyclic AMP-dependent protein kinase during canine lower esophageal sphincter relaxation.
      M S Barnette, M Grous, T J Torphy and H S Ormsbee
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1160-1166;

  11. Tracey, W R

    1. Comparison of spectrophotometric and biological assays for nitric oxide (NO) and endothelium-derived relaxing factor (EDRF): nonspecificity of the diazotization reaction for NO and failure to detect EDRF.
      W R Tracey, J Linden, M J Peach and R A Johns
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 922-928;

  12. Tucker, M

    1. Ethanol inhibits zymosan-stimulated and enhances nonstimulated platelet-activating factor production in a clonal macrophage cell line.
      R C Baker, M Tucker and K L Clay
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1028-1033;

  13. Turndorf, H

    1. Effect of pertussis toxin on the interaction of azepexole and halothane.
      M M Puig, H Turndorf and W Warner
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1156-1159;

V

  1. Vanhoutte, P M

    1. Electrophysiological analysis of adrenergic neurotransmission and its modulation by chronic denervation in canine saphenous veins.
      K Komori, N A Flavahan, V M Miller and P M Vanhoutte
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1197-1201;

  2. Varga, L

    1. Different motor actions of dynorphins and nonpeptide kappa opioid receptor agonists in the isolated rat colon.
      U Scheurer, F Wenger, A Caliezi, E Drack, L Varga and F Halter
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1324-1330;

  3. Vauquelin, G

    1. Chronic isoproterenol administration causes altered beta adrenoceptor-Gs-coupling in guinea pig lung.
      V Nerme, T Abrahamsson and G Vauquelin
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1341-1346;

  4. Voelker, J R

    1. Intratubular albumin blunts the response to furosemide-A mechanism for diuretic resistance in the nephrotic syndrome.
      K A Kirchner, J R Voelker and D C Brater
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1097-1101;

W

  1. Wada, O

    1. Antagonism of gamma-aminobutyric acidA receptor-mediated responses by amino-gamma-carbolines.
      Y Kanai, O Wada and S Manabe
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1269-1276;

  2. Wanstall, J C

    1. Pinacidil antagonism of endothelin-induced contractions of smooth muscle in the lungs: differences between tracheal and pulmonary artery preparations.
      S R O'Donnell, J C Wanstall and X P Zeng
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1318-1323;

  3. Warner, W

    1. Effect of pertussis toxin on the interaction of azepexole and halothane.
      M M Puig, H Turndorf and W Warner
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1156-1159;

  4. Wenger, F

    1. Different motor actions of dynorphins and nonpeptide kappa opioid receptor agonists in the isolated rat colon.
      U Scheurer, F Wenger, A Caliezi, E Drack, L Varga and F Halter
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1324-1330;

  5. West, R E

    1. Sch 37370: a potent, orally active, dual antagonist of platelet-activating factor and histamine.
      M M Billah, R W Chapman, R W Egan, H Gilchrest, J J Piwinski, J Sherwood, M I Siegel, R E West and W Kreutner
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1090-1096;

  6. Westfall, D P

    1. Nerve and drug-induced release of adenine nucleosides and nucleotides from rabbit aorta.
      K O Sedaa, R A Bjur, K Shinozuka and D P Westfall
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1060-1067;

  7. Westmacott, D

    1. Biologic properties of romazarit (Ro 31-3948), a potential disease-modifying antirheumatic drug.
      D P Bloxham, D Bradshaw, C H Cashin, B B Dodge, E J Lewis, D Westmacott and C R Self
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1331-1340;

  8. Whiting, R L

    1. Antagonist characterization of atypical beta adrenoceptors in guinea pig ileum: blockade by alprenolol and dihydroalprenolol.
      D R Blue, R A Bond, N Adham, R Delmendo, A D Michel, R M Eglen, R L Whiting and D E Clarke
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1034-1042;

  9. Wolf, B

    1. Low-dose caffeine discrimination in humans.
      R R Griffiths, S M Evans, S J Heishman, K L Preston, C A Sannerud, B Wolf and P P Woodson
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 970-978;

  10. Woodson, P P

    1. Low-dose caffeine discrimination in humans.
      R R Griffiths, S M Evans, S J Heishman, K L Preston, C A Sannerud, B Wolf and P P Woodson
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 970-978;

Y

  1. Yaksh, T L

    1. The antiseizure activity of dihydropyridine calcium channel antagonists in the conscious rat.
      M A Morón, C W Stevens and T L Yaksh
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1150-1155;

  2. Yamanaka, H

    1. O2-dependent hepatotoxicity due to ethylhexanol in the perfused rat liver: mitochondria as a site of action.
      B J Keller, H Yamanaka, D C Liang, F C Kauffman and R G Thurman
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1355-1360;

  3. Yamatsu, K

    1. Analgesia produced by E-2078, a systemically active dynorphin analog, in mice.
      T Nakazawa, Y Furuya, T Kaneko, K Yamatsu, H Yoshino and S Tachibana
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1247-1254;

  4. Yorio, T

    1. Prostaglandin F2 alpha inhibits acidification in H(+)-secreting epithelia.
      R D Page and T Yorio
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 929-933;

  5. Yoshida, Y

    1. Effects of BRL 34915 (cromakalim) on renal hemodynamics and function in anesthetized dogs.
      K Hayashi, Y Matsumura, Y Yoshida, T Ohyama, K Hisaki, Y Suzuki and S Morimoto
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1240-1246;

  6. Yoshino, H

    1. Analgesia produced by E-2078, a systemically active dynorphin analog, in mice.
      T Nakazawa, Y Furuya, T Kaneko, K Yamatsu, H Yoshino and S Tachibana
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1247-1254;

Z

  1. Zahniser, N R

    1. Effects of the selective adenosine A2 receptor agonist CGS 21680 on in vitro electrophysiology, cAMP formation and dopamine release in rat hippocampus and striatum.
      C R Lupica, W A Cass, N R Zahniser and T V Dunwiddie
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1134-1141;

  2. Zeng, X P

    1. Pinacidil antagonism of endothelin-induced contractions of smooth muscle in the lungs: differences between tracheal and pulmonary artery preparations.
      S R O'Donnell, J C Wanstall and X P Zeng
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1318-1323;
Back to top

In this issue

Advertisement